Patents by Inventor Joseph Grimsby

Joseph Grimsby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190092877
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Application
    Filed: September 17, 2018
    Publication date: March 28, 2019
    Inventors: Anthony CELESTE, Matthieu CHODORGE, Andrew BUCHANAN, Cristina RONDINONE, Joseph GRIMSBY, Peter RAVN, Jonathan SEAMAN, David FAIRMAN
  • Patent number: 10077319
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: September 18, 2018
    Assignees: MedImmune, LLC, MedImmune Limited
    Inventors: Anthony Celeste, Matthieu Chodorge, Andrew Buchanan, Cristina Rondinone, Joseph Grimsby, Peter Ravn, Jonathan Seaman, David Fairman
  • Publication number: 20160369010
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Application
    Filed: February 20, 2015
    Publication date: December 22, 2016
    Inventors: Anthony Celeste, Matthieu CHODORGE, Andrew BUCHANAN, Cristina RONDINONE, Joseph GRIMSBY, Peter RAVN, Jonathan SEAMAN, David FAIRMAN
  • Publication number: 20060178429
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Application
    Filed: April 10, 2006
    Publication date: August 10, 2006
    Inventors: Wendy Corbett, Joseph Grimsby, Nancy-Ellen Haynes, Robert Kester, Paige Mahaney, Jagdish Racha, Ramakanth Sarabu, Ka Wang